Nautilus Biotechnology Inc
(NAUT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 11-1998 | 08-1998 | 05-1998 | 02-1998 | 11-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 49,050 | 28,980 | 9,840 | 56,410 | 42,591 |
| Depreciation Amortization | 9,250 | 6,140 | 2,800 | 10,460 | 7,024 |
| Other Working Capital | -22,020 | -31,530 | 9,760 | -13,260 | -22,142 |
| Other Operating Activity | 310 | 660 | 480 | 1,940 | -47 |
| Operating Cash Flow | $36,590 | $4,250 | $22,880 | $55,550 | $27,426 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,640 | -12,420 | -7,220 | -22,850 | -17,678 |
| Net Acquisitions | -1,650 | 0 | 0 | -2,830 | -2,948 |
| Other Investing Activity | -1,160 | 15,440 | -650 | -52,650 | -57,783 |
| Investing Cash Flow | $-19,450 | $3,020 | $-7,870 | $-78,330 | $-78,409 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -47,230 | -39,750 | 440 | -14,490 | -15,309 |
| Financing Cash Flow | $-47,230 | $-39,750 | $440 | $-14,490 | $-15,309 |
| Beginning Cash Position | 34,610 | 34,610 | 34,610 | 71,880 | 71,887 |
| End Cash Position | 4,510 | 2,130 | 50,060 | 34,610 | 5,595 |
| Net Cash Flow | $-30,090 | $-32,470 | $15,450 | $-37,270 | $-66,292 |
| Free Cash Flow | |||||
| Operating Cash Flow | 36,590 | 4,250 | 22,880 | 55,550 | 27,426 |
| Free Cash Flow | 36,590 | 4,250 | 22,880 | 55,550 | 27,426 |